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Abstract 
 
The ability of phosphonium cations to act as intracellular transport vectors is well-
established.  Previous research has demonstrated that phosphonioalkylthiosulfate 
zwitterions, and -thioacetylalkylphosphonium salts are useful precursors for the 
formation of phosphonium-functionalised gold nanoparticles and enable the 
nanoparticles to be transported into cells for diagnostic and therapeutic purposes.  
In this report we describe the synthesis and characterisation of a series of 
phosphonioalkylthiosulfate zwitterions, and-thioacetylalkylphosphonium salts 
derived from the methoxy-phenylphosphines tris(2,4,6-trimethoxyphenyl)phosphine, 
tris(2,6-dimethoxyphenyl)phosphine and tri(4-methoxyphenyl)phosphine. The 
methoxyphenyl-substituted phosphonium compounds show greater solubility in 
aqueous systems than the corresponding phenyl derivatives and cytotoxicity studies 
reveal that the compounds are significantly less toxic than the related 
triphenylphosphonium derivatives. 
The solid-state structures of the tris(2,4,6-trimethoxyphenyl)- and tris(2,6-
dimethoxyphenyl)-phosphoniopropylthiosulfate zwitterions have been investigated by 
single crystal X-ray crystallography. The differences in the molecular packing of the 
compounds may account for greater solubility of these zwitterions in aqueous 
solutions. 
Keywords 
Phosphonium, zwitterion, crystal structure, mitochondria, cytotoxicity 
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1.0 Introduction 
 
The lipophilic characteristics of organophosphonium cations, and their ability to be 
transported across cell membranes and accumulate in mitochondria, have led to 
widespread interest in their use as medical probes and therapeutics [1,2].  
Consequently phosphonium moieties, especially triphenylphosphonium groups, have 
been conjugated to a wide range of molecules.  
Our own work has focused on the synthesis and biological properties of 
alkylthiosulfate zwitterions [3-6], and alkylthioacetate salts [3,7], conjugated with 
triphenylphosphine and other trialkyl- and triaryl-phosphines [3-7], and also arsines 
[8], which can be used as precursors for the formation of phosphonium- or arsonium-
functionalized gold nanoparticles [4,8], potentially useful species in mitochondria-
targeted pharmaceutical nanotechnology. Other groups have developed and applied 
our methodology [9,10]. Although triphenylphosphonium-functionalized nanoparticles 
are soluble in water and biological media [4,10] and are taken-up by cells [4,9]  the 
parent triphenylphosphonioalkylthiosulfate zwitterions are insoluble in aqueous 
media [3,10]. This observation has prompted us to investigate alternative 
triarylphosphonium groups in an attempt to improve the aqueous solubility of the 
zwitterions. Tris(2,4,6-trimethoxyphenyl)phosphine is a very unusual tertiary aryl 
phosphine [11]. The presence of the methoxy groups increases the basicity of the 
phosphine and also increases the steric bulk of the compound [12]. Tris(2,6-
dimethoxyphenyl)phosphine has a lower basicity, but similar steric properties to 
tris(2,4,6-trimethoxyphenyl)-phosphine, whereas tris(4-methoxyphenyl)phosphine 
has a lower basicity and lower steric bulk than tris(2,4,6-
trimethoxyphenyl)phosphine. Previous work by Liu and coworkers [13,14], showed 
that tri-(4-methoxyphenyl)- and tris(2,4,6-trimethoxyphenyl)phosphonium compounds 
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can be used to functionalize macrocyclic derivatives 1 and 2, that are soluble in 
biological media and which are readily taken up by cells. Their results showed that 
both the 4-methoxy- and the 2,4,6-trimethoxy- compounds are more effective at 
mitochondria-targeting than the analogous triphenylphosphonium derivatives. 
Furthermore, compound 1 is more effective at mitochondria-targeting than the 2,4,6-
trimethoxy species 2. Another important biological application of tris(2,4,6-
trimethoxyphenyl)phosphonium compounds is in the field of proteomics. Cations 
such as the S-pentafluorophenylacetate (3) [15-19], alkylcarboxylates (4) [20], and 
the N-succinimidyloxycarbonylmethyl-derivative (5) [21-23], are used to derivatise 
small molecules, including amines and carboxylic acids, alcohols, aldehydes and 
ketones, and large biomolecules such as proteins and peptides, to enhance their 
detection by mass spectrometry. 
We have exploited the unusual properties of tris(2,4,6-trimethoxyphenyl)phosphine 
and its analogues by incorporating them into phosphoniumalkylthiosulfate zwitterions 
and alkylthioacetate salts and report here our investigations into the chemistry and 
cytotoxicity of these compounds. 
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Chart 1. The structures of compounds 1 - 5 
 
2.0 Results and Discussion 
 
The established method for preparing triarylphosphonioalkylthiosulfate zwitterions, 
and the associated phosphonioalkylthioacetate salts is to reflux the parent tertiary 
phosphine with a bromoalcohol, such as bromopropanol, as shown in Scheme 1. 
The resulting (3-hydroxypropyl)triarylphosphonium bromide salt is then refluxed with 
hydrobromic acid to generate a (3-bromopropyl)triarylphosphonium bromide that can 
be converted into the alkylthiosulfate zwitterion or the thioacetate salt. Unfortunately, 
this synthetic route is not possible for methoxyphenylphosphines because the 
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hydrobromic acid used in the second step preferentially attacks the ether 
substituents. Consequently, an alternative route has been developed, shown in 
scheme 1. This involves treating the methoxyphenylphosphine with an -
dibromoalkane, such as 1,3-dibromopropane, which leads to good yields of the -
bromoalkylphosphonium compounds although care has to be exercised in the initial 
step to avoid the methoxyphenyl phosphine reacting with both ends of the 
dibromoalkane. This is achieved by using a significant excess of the -
dibromoalkane and adding the methoxyphenylphosphine in small amounts over an 
extended period of time. This leads directly to the (3-bromopropyl)methoxyphenyl 
phosphonium bromide that can be converted into the alkylthiosulfate zwitterion or the 
thioacetate salt by refluxing with sodium thiosulfate or potassium thioacetate, 
respectively.  
 
The structures of the compounds prepared in this study and their numbering, are 
shown in scheme 1. Regarding the length of the alkyl chain in the 
phosphonioalkylthiosulfate zwitterions, and-thioacetylalkylphosphonium salts, 
previous studies have shown that a propyl chain is the ideal length. Longer alkyl 
chains tend to produce compounds that form as waxy solids or oils that are difficult 
to handle. Shorter alkyl chains would be less useful for forming functionalized 
nanoparticles. Therefore, in this study we have focused on the propyl derivatives.  
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Scheme 1. Synthetic procedures employed in this study together with a summary of 
the compounds prepared and their numbering. 
 
All compounds have been fully characterized by 31P and 1H NMR spectroscopy, ESI 
mass spectrometry and IR spectroscopy. The results correspond with the proposed 
structures of 6 - 11 and are consistent with published data. Compounds 6 - 11 
dissolve readily in a range of solvents including dichloromethane, water and aqueous 
media. This makes them suitable for cell biology studies. The solubility of zwitterions 
6, 8 and 10 in aqueous media is notable.  Previous research from our own group [3], 
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and others [10], has shown that triarylphosphoniopropylthiosulfate zwitterions 
prepared from triphenyl-, tri(4-fluorophenyl)- and tri(4-tolyl)-phosphine are not so 
soluble in aqueous media. In contrast, the corresponding 
-thioacetylpropyl(triaryl)phosphonium bromide salts are soluble in aqueous media. 
This difference in solubility between the phosphonium zwitterions and phosphonium 
salts was attributed to strong electrostatic interactions that exist between the 
zwitterions in the solid state. These interactions are not present in the corresponding 
-thioacetylpropyltri(aryl)phosphonium salts. The solubility of the phosphonium 
zwitterions reported here can be attributed to the electronic and steric effects of the 
methoxy-substituents.   
2.1 Single crystal X-ray analysis of tris(2,4,6-trimethoxyphenyl) 
phosphoniopropylthiosulfate and tris(2, 6-dimethoxyphenyl) 
phosphoniopropylthiosulfate 
 
Single crystals of 6 and 8 were grown by slow diffusion of diethyl ether into a 
dichloromethane solution of the compound, resulting in the formation of colorless 
crystals. The Bricklebank group has previously reported the structure of the 
triphenylphosphoniopropylthiosulfate zwitterion (12) [5], together with those of the 
tri(4-fluorophenyl)phosphoniopropylthiosulfate (13) [3], and tributylphosphonio-
thiosulfate (14) [3], zwitterions. The other crystallographically-characterized 
thiosulfate zwitterions are the ammonium derivative S-[4-(trimethylammonio)phenyl] 
thiosulfate (15) [24], and the triphenylarsoniopropylthiosulfate zwitterion (16) [8]. 
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Chart 2. The structures of compounds 12 - 16 
The molecular structure of 6 is shown in Figure 1 and selected bond lengths and 
angles in Table 1. The asymmetric unit of 6 contains two independent molecules 
along with a diethyl ether solvent molecule of crystallisation. The molecule containing 
atoms P1, S1 and S2 is referred to as 6A, and that containing atoms P41, S41 and 
S42 is 6B.  Both molecules of 6 are highly disordered which is not unusual for 
derivatives of tris(2,4,6-trimethoxyphenyl)phosphine (All quoted values are for the 
major component). The molecular structure of 8 is shown in Figure 2 and selected 
bond lengths and angles in Table 2. Unlike 6, the structure of 8 is not disordered. 
The asymmetric unit contains one independent molecule together with water of 
crystallisation. 
The bond lengths and angles in the aryl rings of 6 and 8 are unremarkable and are 
similar to those in the parent phosphines, [2,4,6-(MeO)3C6H2]3P [11], and 
[2,6-(MeO)3C6H3]3P [25].  The phosphorus atoms are tetrahedrally coordinated with 
mean C-P-C bond angles of 109.45o in 6A,109.48o in 6B and 109.51o in 8. The 
corresponding values for the triphenyl-, tri-4-fluorophenyl- and tributyl- analogues, 
12, 13 and 14 are 109.47o, 109.46o and 109.47o respectively. The mean C-P-C 
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angles in 6 and 8 are larger than those in the parent phosphines [11,25], but are 
identical to that  in the phosphonium salt methyltris(2,4,6-
trimethoxyphenyl)phosphonium iodide [26]. Other workers [26,27], have observed 
intramolecular P…O interactions between the oxygen of an ortho-methoxy group and 
the phosphorus atom in derivatives of both [2,4,6-(MeO)3C6H2]3P and 
[2,6-(MeO)3C6H3]3P. Both structures have similar intramolecular P…O distances with 
one oxygen generally much closer than its aryl ring equivalent (Table 3). 
The S-S bond length in 8 [2.1024(5)Å] is similar to the S-S bond length in 6A 
[2.080(3)Å] which is shorter than that in 6B [2.145(6)Å]. All of the S-S bonds in the 
phosphonium thiosulfate zwitterions are appreciably shorter than the S-S bond in the 
monoanion of thiosulfuric acid, HSSO3
- [2.155] [28]. The S-O bonds in 6A, which lie 
in the range 1.391(11)Å - 1.441(11)Å, are similar to those in 6B, which range from 
1.399(12)Å to 1.423(9)Å. However, the S-O bonds in 6A and 6B are shorter than 
those in 8 [1.4404(13)Å - 1.4493(12)Å] and 12 - 14. The reason for this difference is 
unclear.  
The packing of molecules of 6 (Figure 3) and 8 (Figure 4) show no significant 
intermolecular interactions between the cationic phosphonium centres and the 
thiosulfate anions. The structure of 6 shows that the zwitterions pack together in a  
loose head-to-tail manner with the thiosulfate anions surrounded by methoxy ligands, 
whereas for 8 the solvent water helps bridge thiosulfate anions together. As noted 
above, the favorable aqueous solubility of zwitterions 6 - 8 possibly results from 
weaker electrostatic interactions between molecules in the solid state. 
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Figure 1 Thermal ellipsoid representation of the structure of compound 6 
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Table 1 Selected bond lengths [Å] and angles [°] in compound 6. 
 
6A 
   
C1P1 1.835(6) O31S1 1.432(4) 
C11P1 1.801(4) O32S1 1.397(5) 
C21P1 1.798(4) O33S1 1.433(4) 
C31P1 1.815(5) S101S102 2.093(10) 
P1C131 1.801(16) O131S101 1.432(11) 
P1C101 1.804(5) O132S101 1.391(11) 
S1S2 2.080(3) O133S101 1.441(11) 
 
C11P1C21 110.6(2) O33S1O32 118.3(3) 
C11P1C131 99.4(10) O33S1O31 114.9(3) 
C21P1C131 104.8(11) O32S1O31 109.7(4) 
C11P1C31 110.7(2) O33S1S2 98.7(2) 
C11P1C101 106.2(2) O32S1S2 108.5(3) 
C21P1C31 103.9(3) O31S1S2 105.1(3) 
C21P1C101 111.4(5) O133S101O132 112(2) 
C131P1C101 123.5(15) O133S101O131 113.8(19) 
C11P1C1 109.3(3) O132S101O131 115.6(19) 
C21P1C1 115.2(5) O133S101S102 98.9(15) 
C31P1C1 107.0(4) O132S101S102 108.1(16) 
C33S2S1 100.27(19) O131S101S102 106.6(16) 
  C133S102S101 97.8(12) 
 
6B 
   
C41P41 1.798(4) O71S41 1.408(8) 
C51P41 1.790(4) O72S41 1.413(10) 
C61P41 1.798(4) O73S41 1.423(9) 
C71P41 1.827(10) S41S42 2.145(6) 
P41C171 1.813(11) O171S141 1.409(9) 
S141S142 2.105(7) O172S141 1.399(12) 
  O173S141 1.422(10) 
    
C51P41C61 107.3(2) O72S41S42 107.3(6) 
C51P41C41 113.2(2) O71S41S42 101.9(5) 
C61P41C41 112.36(19) O73S41S42 106.3(6) 
C51P41C171 113.7(10) C73S42S41 102.4(6) 
C61P41C171 109.0(8) O172S141O173 118.3(9) 
C41P41C171 101.4(10) O172S141O171 117.9(9) 
C51P41C71 110.5(10) O173S141O171 110.7(10) 
C61P41C71 107.4(9) O172S141S142 99.5(7) 
C41P41C71 106.1(9) O173S141S142 100.8(6) 
O72S41O71 114.6(8) O171S141S142 106.4(5) 
O72S41O73 110.7(8) C173S142S141 100.1(5) 
O71S41O73 114.9(8)   
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Figure 2 Thermal ellipsoid representation of the structure of compound 8 
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Table 2 Selected bond lengths [Å] and angles [°] in compound 8. 
 
C1-P1 
 
1.8152(15) 
 
S1-S2 
 
2.1024(5) 
C4-P1 1.8074(16) O1-S2 1.4469(12) 
C12-P1 1.8020(15) O2-S2 1.4493(12) 
C20-P1   1.8073(15) O3-S2 1.4404(13) 
C3-S1 1.8122(17)   
    
C12-P1-C20 104.60(7) O3-S2-O1 114.40(8) 
C12-P1-C4 112.06(7) O3-S2-O2 114.37(8) 
C20-P1-C4 114.60(7) O1-S2-O2 112.65(8) 
C12-P1-C1 113.25(7) O3-S2-S1 101.89(5) 
C20-P1-C1 108.84(7) O1-S2-S1 106.66(5) 
C4-P1-C1 103.66(7) O2-S2-S1 105.52(5) 
C3-S1-S2 100.79(6) 
 
  
 
 
 
 
 
Table 3 Selected intramolecular P…O contacts [Å] in compounds 6 and 8. 
    
6A 
P1…O1 
 
2.75(2) 
 
P1…O21 
 
3.071(42) 
P1…O3 3.13(2) P1…O23 2.828(4) 
P1…O11 3.099(3) P1…O101 2.768(18) 
P1…O13 2.801(3) P1…O103 3.130(15) 
    
6B 
P41…O41 
 
3.085(3) 
 
P1…O53 
 
2.736(3) 
P41…O43 2.816(4) P1…O61 3.103(3) 
P41…O51 3.115(4) P1…O63 2.790(4) 
    
8 
P1…O4 
 
2.7991(12) 
 
P1…O7 
 
3.0853(12) 
P1…O5 3.0746(12) P1…O8 2.8003(12) 
P1…O6 2.7572(12) P1…O9 3.0774(12) 
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Figure 3. Molecular packing in 6 
 
Figure 4. Molecular packing in 8 
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2.2 Cytotoxicity screening of 6 - 11. 
 
The use of phosphonium cations to transport a variety of species, including drugs, 
diagnostic probes, and nanomaterials, is well-established [1,2]. The advantages of 
phosphonium systems include their ease of synthesis but also, more importantly, 
their stability and lack of reactivity towards cellular components. For medical 
applications it is desirable that the transport vector, in this case the phosphonium 
group, is not reactive or toxic towards cells. Although the biological behaviour of 
phosphonium compounds has been widely investigated, especially their 
mitochondria-targeting properties and antiproliferative effects, perhaps surprisingly, 
few studies of the cytotoxicity of the compounds have been reported [1,2,29]. 
Previous research into triphenylphosphonium-conjugated compounds indicated that 
the toxicity was associated with the triphenylphosphonium moiety rather than the 
side chain [30]. To the best of our knowledge there are no reports of cytotoxicity 
studies into methoxyphenylphosphonium derivatives.  
 
Cell viability studies on compounds 6- 11 were performed against the PC3 prostate 
cancer cell line using MTT and CellTitre-Glo assays. MTT measures mitochondrial 
activity to determine the in vitro cytotoxic effects of chemical entities whereas 
CellTitre-Glo assay uses luminescence to determine the number of viable cells 
based on a quantification of adenosine triphosphate levels. The results are shown in 
Figure 5 and summarised in Table 4. The data from both assays show a similar trend 
with zwitterions 6, 8, 10 displaying greater toxicity to cells after 72 hours than the 
corresponding thioacetate salts 7, 9, 11. The IC50 values for 6 - 11 compare very 
favorably with those of the analogous -thioacetylpropyl(triphenyl)phosphonium salt 
17 and -thioacetylpropyl(4-fluorophenyl)phosphonium salt 18 reported previously 
17 
 
by us [3] and show much lower cytoxicity than the triphenylphosphonium derivative. 
This indicated that the methoxyphenylphosphonium compounds would be potentially 
useful species for transporting drug and diagnostic moieties into cells. 
 
A   
   
   
 
B 
  
   
   
 
 
Figure 5. PC3 cells treated with 6 - 11 for 24, 48, 72 hours. A Cell proliferation 
determined by the MTT assay. B Cell proliferation determined by the CellTiter-Glo 
luminescent cell viability assay kit. All data are expressed as a percentage of living 
cells normalized to control. 
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Table 4. IC50 data for 6 - 11 and related phosphonium compounds after 72 hours. All 
values are µM. 
 
Compound  CellTiter-Glo MTT 
6 218.3 45.65 
7 289.6 66.09 
8 198.1 47.80 
9 328.7 74.00 
10 249.9 58.70 
11 319.3 68.22 
17* 67.1  
18* 252.6  
NOTES 
*Data reported in reference 3 
 
 
 
 
 
17 18 
3. Conclusion 
 
The aim of the work reported in this paper was to synthesize 
methoxyphenylphosphoniopropylthiosulfate zwitterions and -thioacetylpropyl 
(methoxyphenyl)phosphonium bromide salts (6 - 11) and determine their cytotoxicity 
towards PC3 cells. All compounds are easily prepared and, unlike other 
triarylphosphoniopropylthiosulfate zwitterions, they are soluble in water and aqueous 
media.  Cell viability results show the IC50 values for the methoxy-
phenylphosphonium compounds to be much higher than the analogous 
P S
OBr
P S
F
F
F
OBr
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triphenylphosphonium species and compounds 6 - 11 are only cytotoxic towards 
cells at very high concentrations making them well-suited as transport vectors for 
biological applications. These results indicate that methoxy-phenylphosphonium 
compounds offer advantages compared to their phenyl congeners and could be ideal 
for the surface-functionalization of gold nanoparticles for applications in the area of 
mitochondria-targeted pharmaceutical nanotechnology. 
4. Materials and Methods 
 
Synthesis of 6 - 11. 
All chemicals and solvents were purchased from Sigma-Aldrich or Acros Organics 
and used as received. All 1H and 31P NMR spectra were recorded on a Brucker 
AVANCE III (400 MHz). IR spectra were recorded on a Brucker ALPHA platinum 
ATR spectrometer. Melting points were determined on a Stuart SMP3 melting point 
apparatus and are uncorrected. Electrospray Ionisation Mass spectrometry was 
performed on a Thermo Finnigan LCQ classic in positive ion mode. Samples were 
dissolved in a mixture of ethanol and deionised water (50:50) to a concentration of 
approximately 1 mg/mL for molecular ion determination.   Elemental analyses were 
performed by MEDAC Ltd, Chobham, Surrey, UK. 
 
All six compounds were prepared in a similar manner, as exemplified by the 
preparation of compounds 6 and 7. 
Tris(2,4,6-trimethoxyphenyl)phosphine (1.0g, 1.878 x 10-4 mol), dissolved in 
acetonitrile (20 mL), was added dropwise to a 1,3-dibromopropane (5 mL, 1.245 x 
10-2 mol) under a nitrogen atmosphere. The mixture was refluxed for 18 hours. The 
product, 3-bromopropyl[tris(2,4,6-trimethoxyphenyl)]phosphonium bromide was 
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isolated by diluting the reaction mixture with deionised water (20 mL) followed  by 
liquid-liquid extraction using dichloromethane (3 x 10 mL). The dichloromethane 
extracts were combined, dried over MgSO4, and the solvent removed by rotary 
evaporation yielding the product as a white solid. To produce zwitterion 6, 3-
bromopropyl tris(2,4,6-trimethoxyphenyl)phosphonium bromide (0.250 g, 3.82 x 10-4 
mol) and Na2S2O3 (0.212 g, 8.56 x 10
-4 mol) were heated under reflux in aqueous 
ethanol under a nitrogen atmosphere for 18 hours. The thioacetate salt 7 was 
produced by refluxing 3-bromopropyl tris(2,4,6-trimethoxyphenyl)phosphonium 
bromide (0.250 g, 3.82  x 10-4 mol)  and KSC(O)CH3 (0.098 g, 8.56 x 10
-4 mol) in 
aqueous ethanol overnight. Both compounds were isolated from the reaction 
mixtures by extraction with dichloromethane (3 x 20 mL). Purification of the products, 
which form as white microcrystalline powders, was achieved by triturating with 
diethyl ether and recrystallizing from dichloromethane/diethyl ether. The progress of 
all of the reactions was monitored by TLC using a mobile phase of 80% 
dichloromethane : 20% methanol.  
Tris(2,4,6-trimethoxyphenyl)phosphoniopropylthiosulfate (6) 
White solid, M.P.  218 °C. Elemental Analysis: found: C, 52.76%; H, 5.86%; S, 
9.29% requires: C, 52.47%; H, 5.67%; S 9.30%. 1H NMR: 1.23 (2H, m, P-CH2), 
1.89 (2H, m, S-CH2), 3.22 (2H, m, CH2-CH2-CH2), 3.91 (18H, s, o-OCH3), 3.65 (9H, 
s, p-OCH3), 6.09 (6H, d, C6H2) ppm. 
31P NMR (CDCl3) = 5.24 ppm.  IR max/cm
-1 
2912 (CH), 1483, 1438, 1209 (SO), 1082, 1010 (SO), 744, 688, 623, 523, 466. ESI-
MS (m/z): 686.4 [((2,4,6-MeO)3C6H2)3P(CH2)3S2O3], 708.86 [((2,4,6-MeO)3C6H2)3P-
(CH2)3S2O3+Na
+]. 
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-thioacetylpropyltris(2,4,6-trimethoxyphenyl)phosphonium bromide (7) 
White solid, M.P. 243 °C. Elemental Analysis: found: C, 53.83%; H, 5.62%; S 5.03%, 
requires: C, 53.62%; H, 5.54%; S 5.03%. 1H NMR: 1.24 (2H, m, P-CH2), 1.61 (3H, 
s, C(O)CH3), 1.89 (2H, m, S-CH2), 3.57 (2H, m, CH2-CH2-CH2), 3.67 (18H, s, o-
OCH3), 3.03 (9H, s, p-OCH3), 6.16 (6H, d, C6H2) ppm.  
31P NMR (CDCl3) = 5.27 
ppm. IR max/cm
-1 2912 (CH), 1483, 1438, 1209 (SO), 1082, 1010 (SO), 744, 688, 
623, 523, 466. ESI-MS (m/z): 649.33 [((2,4,6-MeO)3C6H2)3P(CH2)3SC(O)CH3], 
650.38 [((2,4,6-MeO)3C6H2)3P(CH2)3SC(O)CH3+H
+]. 
 
Tris(2,6-dimethoxyphenyl)phosphoniopropylthiosulfate (8) 
White solid, M.P. 237 °C. Elemental Analysis: found: C, 52.42%; H, 5.51%; S 
10.19%, requires: C, 52.34%; H, 5.53%; S 10.33%. 1H NMR: 1.25 (2H, m, P-CH2), 
1.84 (2H, m, S-CH2), 3.12 (2H, m, CH2-CH2-CH2), 3.66 (18H, s, o-OCH3), 6.61 - 7.61 
(9H, m, C6H3) ppm.  
31P NMR (CDCl3) = 7.54 ppm. IR max/cm
-1 2912 (CH), 1483, 
1438, 1209 (SO), 1082, 1010 (SO), 744, 688, 623, 523, 466. ESI-MS (m/z): 596.4 
[((2,6-MeO)2C6H3)3P(CH2)3S2O3], 619.33 [((2,6-MeO)2C6H3)3P(CH2)3S2O3+Na
+]. 
 
-thioacetylpropyltri(2,6-dimethoxyphenyl)phosphonium bromide (9) 
White solid, M.P. 226 °C. Elemental Analysis: found: C, 54.31%; H, 5.90%; S 4.98%, 
requires: C, 54.46%; H, 5.63%; S 5.00%.1H NMR: 1.18 (2H, m, P-CH2), 1.72 (3H, 
s, C(O)CH3), 1.65 (2H, m, S-CH2), 3.22 (2H, m, CH2-CH2-CH2), 3.64 (18H, s, o-
OCH3), 6.61 - 7.61 (9H, m, C6H3) ppm. 
31P NMR (CDCl3) = 7.31 ppm. IR max/cm
-1 
2912 (CH), 1483, 1438, 1209 (SO), 1082, 1010 (SO), 744, 688, 623, 523, 466. ESI-
MS (m/z): 559.37 [((2,6-MeO)2C6H3)3P(CH2)3SC(O)CH3], 560.38 [((2,6-
MeO)2C6H3)3P(CH2)3 SC(O)CH3+H
+]. 
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Tri(4-methoxyphenyl)phosphoniopropylthiosulfate (10) 
White solid, M.P. 195 °C. Elemental Analysis: found: C, 57.11%; H, 5.64%; S 10.2%, 
requires: C, 57.01%; H, 5.33%; S 10.62%. 1H NMR: 2.15 (2H, m, P-CH2), 3.25 (2H, 
m, S-CH2), 3.45 (2H, m, CH2-CH2-CH2), 3.9 (9H, s, OCH3), 7.1–7.6 (12H, m, C6H4) 
ppm. 31P NMR (CDCl3) = 21.28 ppm. IR max/cm
-1 2912 (CH), 1483, 1438, 1209 
(SO), 1082, 1010 (SO), 744, 688, 623 (CS), 523, 466. ESI-MS (m/z): 507.2 [(4-
MeOC6H4)3P(CH2)3S2O3], 529.2 [(4-MeOC6H4)3P(CH2)3S2O3+Na
+]. 
 
-thioacetylpropyltri(4-methoxyphenyl)phosphonium bromide (11) 
White solid, M.P. 207 °C. Elemental Analysis: found: C, 57.06%; H, 5.53%; S 5.88%, 
requires: C, 56.83%; H, 5.28%; S 5.82%. 1H NMR: 2.17 (2H, m, P-CH2), 2.3 (3H, s, 
C(O)CH3), 3.22 (2H, m, S-CH2), 3.37 (2H, m, CH2-CH2-CH2), 3.90 (9H, s, OCH3), 
7.1–7.6 (12H, m, C6H4) ppm 
31P NMR (CDCl3) = 21.33 ppm. IR max/cm
-1 2912 (CH), 
1483, 1438, 1209 (SO), 1082, 1010 (SO), 744, 688, 623, 523, 466. ESI-MS (m/z): 
469.34 [(4-MeOC6H4)3P(CH2)3SC(O)CH3], 471.35 [(4-MeOC6H4)3P(CH2)3SC(O)CH3 
+H+]. 
Cytotoxicity assay 
Cytotoxicity was assessed using a CellTiter-Glo luminescent cell viability assay kit 
(Promega Corporation, Southampton, Hampshire, UK). PC3 cells were grown in 
DMEM (Dulbecco's Modified Eagle's medium) supplemented with 10% Foetal calf 
serum (Invitrogen) at 37ºC in 5% C02. Cells were seeded in opaque-walled 96 well 
plates at a density of 10,000 cells/well and allowed to adhere overnight. Cells were 
subsequently treated with the corresponding phosphonium ligand (0-1000m) for 24, 
48, 72 hours. After each incubation period, cell viability was measured according to 
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the manufacturer’s instructions. In brief, plates were equilibrated at room 
temperature for 30 mins, 100l of assay reagent was added to each well, placed on 
an orbital shaker for 2mins, left to stand at room temperature for 10 minutes and 
read on a Wallac Victor2 1420 multilabel counter (PerkinElmer, Cambridge, 
Cambridgeshire, UK). 
 
Cytotoxicity studies were also done to assess IC50 using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay as a measure of succinate 
dehydrogenase activity in live cells. Cells were seeded in a 96 well plate with the 
corresponding ligand (0-1000 m) for 24, 48, 72 hours. MTT was added to each well 
to give a final concentration of 0.3 mg/mL MTT and cells incubated with MTT for 3-4 
hours at 37oC. The growth medium was then removed and 100 L DMSO was 
added and incubated for 30 mins prior to reading the absorbance at 570 nm.  
 
All plates contained control wells and all measurements were performed in 
quadruplicates, and three independent experiments were conducted (n=12). Data 
are expressed as a percentage of live cell succinate dehydrogenase activity 
normalized to control. The average, standard deviation and IC50 values were plotted 
and calculated using GraphPad Prism (GraphPad software, La Jolla, California, 
USA). 
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X-ray crystallography 
Crystal Data for 6. C32H44O12.5PS2, Mr = 723.76, triclinic, P-1, a = 12.2703(4) Å, b = 
15.4855(4) Å, c = 19.4439(3) Å, α = 72.212(4)°, β = 85.475(5)°, γ = 84.543(5)°, V = 
3497.16(18) Å3, T = 120(2) K, Z = 4, Z' = 2, λ(Mo K) = 0.255, 53536 reflections 
measured, 15979 unique (Rint = 0.056) which were used in all calculations. The final 
wR2 was 0.2882 (all data) and R1 was 0.1086 (I > 2(I)). 
Crystal Data for 8. C27H35.33O10.17PS2, Mr = 617.65, monoclinic, P21/c, a = 
13.9991(2) Å, b = 18.4241(2) Å, c = 11.28730(10) Å, β = 99.1340(10)°, α = γ = 90°, 
V = 2874.31(6) Å3, T = 120(2) K, Z = 4, Z' = 1, λ(MoK) = 0.297, 58735 reflections 
measured, 6571 unique (Rint = 0.0540) which were used in all calculations. The final 
wR2 was 0.0917 (all data) and R1 was 0.0363 (I > 2(I)). 
Suitable crystals were selected and data collected following a standard method [32]. 
For compound 6 on a Rigaku SPIDER RAPID diffractomer at 120K with an image 
plate detector. Cell determination and data collection, data reduction, cell refinement 
and absorption correction were carried out using CrystalClear [33]. For compound 8 
on a Nonius Kappa CCD diffractometer at 120K controlled by the Collect [34] 
software package. The data were processed using Denzo [35] and semi-empirical 
absorption corrections were applied using SADABS [36]. Using Olex2 [37] both 
structures were solved using SHELXT [38] and models refined with SHELXL [39]. 
 All non-hydrogen atoms were refined anisotropically, with all hydrogen atoms placed 
geometrically using standard riding models 
CCDC1826927 and 1826926 contain the supplementary crystallographic data for 
compounds 6 and 8 respectively for this paper. These data can be obtained free of 
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charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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